Valuation Thiogenesis Therapeutics, Corp. OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 19:27:52 05/06/2026 +04			5-day change	1st Jan Change
0.4200 ^USD	-6.67%		-.--%	-28.01%

07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI
07-13	Thiogenesis Therapeutics' Treatment For Leigh Syndrome Receives FDA Rare Pediatric Disease Designation	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	22.54	33.43	27.61	33.69
Change	-	48.3%	-17.4%	22.03%
Enterprise Value (EV) ¹	16.34	26.35	23.76	32.08
Change	-	61.23%	-9.83%	34.99%
P/E	-3.74x	-5.8x	-8.65x	-4.25x
PBR	3.77x	6.04x	8.06x	58.7x
PEG	-0x	0.3x	0.2x	-0x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-	-	-
EV / EBIT	-8.14x	-5.06x	-6.64x	-4.34x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ³	-	-	-	-
Rate of return	-	-	-	-
EPS ³	-0.1552	-0.1294	-0.0693	-0.1528
Distribution rate	-	-	-	-
Net sales	-	-	-	-
EBITDA	-	-	-	-
EBIT ¹	-2.009	-5.206	-3.579	-7.395
Net income ¹	-3.924	-5.063	-3.146	-7.426
Net Debt ¹	-6.196	-7.076	-3.848	-1.616
Reference price ³	0.5800	0.7500	0.6000	0.6500
Nbr of stocks (in thousands)	38,862	44,571	46,017	51,836
Announcement Date	28/04/23	29/04/24	25/04/25	30/04/26

¹CAD in Million²USD in Million³CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	32.79x	5.87x	17.42x	1%	47.74B
REVOLUTION MEDICINES, INC.	-23.47x	352.2x	-21.51x	-.--%	39.98B
BEONE MEDICINES AG	48.32x	4.93x	31.87x	-.--%	36.23B
IQVIA HOLDINGS INC.	25.95x	2.85x	12.32x	-.--%	35.59B
CELLTRION, INC.	27.91x	7.98x	19.84x	0.43%	27.91B
MEDPACE HOLDINGS, INC.	33.62x	5.49x	25.05x	-.--%	16.45B
EUROFINS SCIENTIFIC SE	22.1x	1.97x	8.54x	1.19%	13.21B
ICON PUBLIC LIMITED COMPANY	23.86x	1.9x	11.51x	-.--%	12.93B
Average	23.88x	47.90x	13.13x	0.33%	28.76B
Weighted average by Cap.	22.75x	65.23x	12.14x	0.33%